According to Lehmann and Deutsch, self-monitoring blood glucose (SMBG) data, metabolic compartment models, and blood glucose measurements were combined into a platform that assisted doctors in fine-tuning insulin dosage assessments at T1DM patient consultations [161]. This evidence concerns the gene INS and type 1 diabetes mellitus.